European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Hideyuki Kuwabara et al.|Cancer Science|2013Cited by 39
Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphomaSatoshi Koyama, Hideaki Nakajima, Shin Fujisawa et al.|International Journal of Laboratory Hematology|2016Cited by 35
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Hideaki Nakajima, Taiki Andou et al.|Clinical Lymphoma Myeloma & Leukemia|2018Cited by 28
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Hideaki Nakajima, Shin Fujisawa et al.|Asia-Pacific Journal of Clinical Oncology|2018Cited by 7
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective StudyHiroyuki Takahashi, Hideaki Nakajima, Rika Sakai et al.|Indian Journal of Hematology and Blood Transfusion|2020Cited by 6